I-Mab to Present at 24th Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

I-Mab (NASDAQ: IMAB), a US-based global biotech company specializing in precision immuno-oncology treatments for cancer, has announced its upcoming participation in the 24th Annual Needham Virtual Healthcare Conference. The conference is scheduled to take place from April 7-10, 2025.

The company's management team will be present at this virtual healthcare event, which serves as a significant platform for biotechnology companies to showcase their developments and connect with industry stakeholders.

News Market Reaction

-3.94%

1 alert

-3.94% News Effect

On the day this news was published, IMAB declined 3.94%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

ROCKVILLE, Md., March 26, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB), a US-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab’s management team will participate in 24^th Annual Needham Virtual Healthcare Conference, being held April 7-10, 2025.

Details are as follows:

24th Annual Needham Virtual Healthcare Conference
Conference Date:	April 7-10, 2025
Format:	Company Presentation and one-on-one meetings
Presentation Time:	Monday, April 7, 2025, 8:45 to 9:25 AM ET
Webcast Link:	Register here

About I-Mab

I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and Short Hills, New Jersey. For more information, please visit us at: https://www.i-mabbiopharma.com/ and follow us on LinkedIn and X.

I-Mab Investor & Media Contacts
PJ Kelleher
LifeSci Advisors
+1 617-430-7579
pkelleher@lifesciadvisors.com
IR@imabbio.com

FAQ

When is I-Mab (IMAB) presenting at the Needham Healthcare Conference 2025?

I-Mab will present at the 24th Annual Needham Virtual Healthcare Conference taking place from April 7-10, 2025.

What type of company is I-Mab (IMAB) and what is their focus?

I-Mab is a US-based global biotech company focused on developing precision immuno-oncology agents for cancer treatment.

Is the Needham Healthcare Conference 2025 virtual or in-person?

The 24th Annual Needham Healthcare Conference is being held virtually.

Which stock exchange is I-Mab (IMAB) listed on?

I-Mab (IMAB) is listed on the NASDAQ stock exchange.